HANCOCK, Md.–(BUSINESS WIRE)–PetLife Pharmaceuticals, Inc. (OTCQB:PTLF) (the “Company”), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, released today an overview of the $63 billion companion pet healthcare industry. Empty nesters, reduced fertility, and pet owners prioritizing pet care over their own expenses all contribute to the resiliency of the pet care industry. PetLife’s continuous development of multiple product lines aims to serve the growing companion pet healthcare market, bolstering its market reach and thereby solidifying the company both on a revenue/financial point of view as a natural, solution-focused company.
Keep reading this article on businesswire
source http://www.omnipopmag.com/2017/03/07/petlife-pharmaceuticals-provides-an-eye-opening-view-on-a-recession-resistive-industry/
No comments:
Post a Comment